Epperly Melissa B, 4

What Happened

• Melissa B. Epperly, a director of Roivant Sciences Ltd. (ROIV), sold 41,861 common shares in an open-market transaction on March 16, 2026. The reported weighted-average price was $28.68 per share, for total proceeds of approximately $1,200,573. This was a sale (not a purchase or option exercise).

Key Details

• Transaction date: 2026-03-16 (reported on Form 4 filed 2026-03-18, accession 0001807359-26-000004). Filing appears timely.
• Transaction type/code: Open-market sale (S).
• Shares sold: 41,861; weighted-average price: $28.68; total proceeds: ~$1,200,573.
• Price range: Shares were sold in multiple trades at prices from $28.50 to $28.84 (footnote indicates the reporting person can provide exact breakdown on request).
• Shares owned after the transaction: Not specified in the information provided on this filing.
• Footnotes: F1 notes the weighted-average price and the per-trade price range; additional per-price detail is available upon request to the issuer or SEC staff.

Context

• This was an open-market sale by a company director. Sales by insiders can be routine (for diversification, liquidity, tax planning, etc.) and do not by themselves prove a change in the insider’s view of the company. Purchases generally carry more direct informational weight than routine sales.